Home Featured Page 134

Featured

Latest

Optimi Health Initiates Agreement With SABI Mind For Therapeutic Supplies Of Psilocybin, MDMA

HAVN Life Enters Supply Agreement with MPB Group Inc.

PsyBio Therapeutics to Seek Approval of Proposed Share Consolidation at Annual and Special Meeting of Shareholders

Numinus Unveils New Logo and Brand Identity

Bright Minds Biosciences Announces Changes to its Executive Leadership Team, Marking the Transition to a Development Organization

You Don’t Have to Take Psychedelics to Benefit from Them —...

PTSF 44 (with Colin Thompson, director of “Light Years”)

PT228 – Deborah Snyder from Synergetic Press

PT227- Dr. Anne Wagner – Couples Therapy, MDMA, and MAPS

PT226 – Veronika Gold & Harvey Schwartz from Polaris Insight Center

PT229 – Dr. Matthew Johnson – What is Consciousness?

Light Years – Film Screening and Panel Discussion

1...133134135...141 Page 134 of 141

EDITOR PICKS

Optimi Health Initiates Agreement With SABI Mind For Therapeutic Supplies Of...

HAVN Life Enters Supply Agreement with MPB Group Inc.

PsyBio Therapeutics to Seek Approval of Proposed Share Consolidation at Annual...

William Leonard Pickard participating in celebration for Sasha Shulgin’s new book...

Having Sex on DMT: What You Need to Know

PTSF49 – MDMA For Alcoholism, The Placebo Effect, and Ceremonial Magicians

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Optimi Health Initiates Agreement With SABI Mind For Therapeutic Supplies Of Psilocybin, MDMA

HAVN Life Enters Supply Agreement with MPB Group Inc.

PsyBio Therapeutics to Seek Approval of Proposed Share Consolidation at Annual and Special Meeting of Shareholders

Numinus Unveils New Logo and Brand Identity

Bright Minds Biosciences Announces Changes to its Executive Leadership Team, Marking the Transition to a Development Organization

You Don’t Have to Take Psychedelics to Benefit from Them —...

PTSF 44 (with Colin Thompson, director of “Light Years”)

PT228 – Deborah Snyder from Synergetic Press

PTSF 43

PT227- Dr. Anne Wagner – Couples Therapy, MDMA, and MAPS

PTSF 42

PT226 – Veronika Gold & Harvey Schwartz from Polaris Insight Center

PTSF 45

PT229 – Dr. Matthew Johnson – What is Consciousness?

Light Years – Film Screening and Panel Discussion

EDITOR PICKS

Optimi Health Initiates Agreement With SABI Mind For Therapeutic Supplies Of...

HAVN Life Enters Supply Agreement with MPB Group Inc.

PsyBio Therapeutics to Seek Approval of Proposed Share Consolidation at Annual...

POPULAR POSTS

William Leonard Pickard participating in celebration for Sasha Shulgin’s new book...

Having Sex on DMT: What You Need to Know

PTSF49 – MDMA For Alcoholism, The Placebo Effect, and Ceremonial Magicians

POPULAR CATEGORY